Ocular Therapeutix rises on OTX-TP update

By BC Staff | Feb 18, 2016 | 2:44 AM GMT

Ocular Therapeutix Inc. (NASDAQ:OCUL) jumped $2.41 (39%) to $8.67 on Wednesday after it announced plans for two Phase III